Thursday, August 25, 2016

It's mylan, not maylan. Well, even the Washington post makes mistakes.

"This is the same year Maylan bought the rights to EpiPen."

https://www.washingtonpost.com/news/the-fix/wp/2016/08/24/how-a-senators-daughter-became-ceo-of-the-company-at-the-center-of-the-epipen-controversy/?postshare=8231472131004263&tid=ss_fb

No comments: